Spinal Traction Market Share, Industry Analysis and Global Forecast to 2030

Market Synopsis

According to a new report by Market Research Future (MRFR), The spinal traction market size is expected to reach USD 4,561.49 Million by 2030 at 8.51% CAGR during the forecast period 2022-2030. owing to the growing geriatric population. Spinal traction devices are used to stabilize and decompress the spine for treating several spinal disorders and orthopedic conditions like bone fractures, muscle contracture, and bone deformities like kyphosis, scoliosis, and lordosis. These devices are also used in treating low back pain and muscle spasms. Spinal traction devices are also used to prepare patients for surgical procedures like interbody fixation, endoscopic spine surgery, vertebral compression fracture repair, and interspinous fixation.

The spinal traction market has witnessed significant growth and innovation in recent years, driven by a rising prevalence of spinal disorders, an aging population, and advancements in medical technology. Spinal traction, a therapeutic technique used to alleviate pain and restore spinal function, has evolved to encompass various approaches, both surgical and non-surgical. This article delves into the current state of the spinal traction market, exploring key trends, innovations, and factors shaping its growth.

Global Spinal Traction Market Segmentation

The global market for spinal traction has been segmented on the basis of diagnosis, type, treatment, end-users, and region.

The market has been segmented into mechanical spinal traction and manual spinal traction based on types. The market has been segmented into herniated discs, sciatica, facet disease, slipped discs, bone spurs, foraminal stenosis, pinched nerves, and degenerative disc disease, based on applications. The market has been segmented into gravity-dependent traction, manual traction, and continuous traction based on devices.

The market has also been segmented into academic and research, hospitals and clinics, and others based on end-users. Among these, the segment for hospital dominated the global market for spinal traction and is predicted to maintain its dominance over the assessment period.

Regional Analysis

Geographically, the market for spinal traction has been spanned across regions such as North America, the Middle East and Africa, Europe, and Asia Pacific.

The North American region is anticipated to hold the largest market share due to the high expenditure on healthcare. Also, adoption of medical devices and new diagnostics in the U.S. is also expected to drive the market in this region. Moreover, the presence of large hospital networks and major healthcare companies in the developed countries is propelling the market growth over the assessment period.

Europe holds the second largest position after North America, owing to the penetration of strong healthcare and high income in this region. Countries such as France and Germany are expected to lead the market growth in the European region. The UK is anticipated to emerge as the fastest growing market over the review period due to the presence of strong pharmaceutical industry.

Asia Pacific is estimated to grow rapidly over the assessment period. India and China are likely to lead the market owing to the huge unmet requirement and fast-growing healthcare sector over the assessment period. Moreover, South East Asian countries like India, China, and Malaysia are estimated to contribute to the market growth. Also, increasing penetration of healthcare insurance in the Asia Pacific region is anticipated to spur the market growth in this region.

Moreover, the UAE and Saudi Arabia are anticipated to drive the Middle East and African market. The African region is expected to witness moderate growth due to poor political and economic conditions.

Industry News

Natural compounds derived from Australian plants have been found to stimulate cells and are useful for transplantation to repair injuries in the spinal cord. The results have been published in the Scientific Reports by a team of scientists recently at the Menzies Health Institute Queensland and Griffith Institute for Drug Discovery.

Competition Analysis

 The prominent players operating the spinal traction market are Stoll Medizintechnik GmbH, Spinal Designs International Inc., Saunders Group Inc., SpineRx Technology, VAX-D Medical Technologies LLC., Scrip, Inc. BTL, North American Medical (NAM) Corporation, Spinetronics, LLC, Dentsply International, Medtronic Inc., CERT Health Sciences LLC, Hill Laboratories Company, and others.

Future Drivers and Constraints

Increasing production number of spinal surgery, implants, and ongoing researches for improving the quality of care are expected to create attractive growth opportunities for the market globally. With the increasing cases of trauma and spinal cord diseases, growing geriatric population, increase in the number of spinal surgeries, screening and awareness, and developing healthcare are some of the factors propelling the market growth over the review period.

Also, the shift in the preference among patients and surgeons for adopting minimally invasive (MI) surgery over traditional surgeries have resulted in the development of advanced spinal implants. The rising number of clinical trials of latest technology implants is also propelling the market growth over the assessment period.

Innovation has remained the best strategy with companies focusing on developing new devices which can offer better treatment and diagnostic to various types of spine conditions. Wireless sensor technology is one of the latest researches with advanced products connected to external devices for analysis and healing progress.

Meanwhile, costly devices, lack of experimental clinical data in medical treatment, risk related after surgery which comprises risk of damage and infection to the spine, and demand for minimally invasive procedures is assessed to hamper the growth of the market over the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Exploring the Transformative Potential of mixed reality in healthcare market

The mixed reality in healthcare market is expected to register a CAGR of 25.04% during the forecast period of 2022 to 2030, with an estimated market value of USD 9722.85 million in 2030. The field of healthcare is constantly evolving, driven by technological advancements that seek to improve patient care, enhance medical training, and streamline clinical workflows. One such innovation making significant waves in the industry is Mixed Reality (MR). Mixed Reality combines elements of the physical and virtual worlds to create immersive and interactive experiences, and its applications in healthcare are revolutionizing the sector in myriad ways. Mixed Reality Defined Mixed Reality is a fusion of both Augmented Reality (AR) and Virtual Reality (VR). While AR overlays digital information onto the real world, VR immerses users entirely into a computer-generated environment. MR, on the other hand, seamlessly blends these two experiences, allowing users to interact with virtual objects w...
Read more

Insulin Biosimilars Market Report, Key Trends, Competitive Scenario, Current and Future Players 2032

Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. According to MRFR analysis, Insulin Biosimilars Market size is expected to reach USD 1.68 billion by 2032 at a CAGR of 14.6% during the forecast period of 2023 to 2032. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’s) Biosimilar p...
Read more

Leuprolide Acetate Market Share, Analysis and Projection, Region - Global Forecast to 2030

Market Scenario The leuprolide acetate market size is projected to reach USD 2,400 Million by 2030 at 10.50% CAGR during the forecast period 2022-2030. Leuprolide acetate is a medication used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty . The medication works by decreasing testosterone levels in men and estrogen levels in women . The report states that the increasing prevalence of prostate cancer and endometriosis is expected to drive the growth of the leuprolide acetate market in the projected timeframe . The report also highlights that side effects such as hot flashes, night sweats, decreased libido, erectile dysfunction, and osteoporosis associated with leuprolide acetate treatment are some factors which will likely act as market restraints for the growth of the leuprolide acetate market in the above mentioned projected timeframe . Key Players: GPI Golrang pharmaceutical investment (Russia), Bachem(Switzerland), avenit AG (...
Read more